Literature DB >> 33239274

Which factors are associated with bone marrow oedema suspicious of axial spondyloarthritis as detected by MRI in the sacroiliac joints and the spine in the general population?

Xenofon Baraliakos1, Adrian Richter2,3, Daniel Feldmann4, Anne Ott5, Robin Buelow6, Carsten O Schmidt7, Juergen Braun8.   

Abstract

OBJECTIVE: Identify factors associated with presence and extension of spinal and sacroiliac joints (SIJ)-MRI lesions suggestive of axial spondyloarthritis (axSpA) in a population-based cohort (Study of Health in Pomerania) aged <45 years.
METHODS: Spinal (sagittal T1/T2) and SIJ (semicoronal STIR sequences) MRIs were evaluated by two trained blinded readers. The presence (yes/no) and extension (Berlin MRI Score) of bone marrow oedema (BME) were captured. Degenerative spinal lesions were excluded and discrepancies resolved by consensus. Cross-sectional associations between clinical factors and presence/extension of BME were analysed by logistic/negative binomial regression. Record linkage of claims data was applied to identify participants with axSpA.
RESULTS: MRIs of 793 volunteers were evaluated. The presence of SIJ-BME (odds ratio) was strongly associated delivery during the last year (4.47, 1.49-13.41). For SIJ-BME extension, associations (incidence rate ratios, 95% CI) were found for delivery ((during last year) 4.52, 1.48-13.84), human leucocyte antigen (HLA)-B27+ (2.32, 1.30-4.14), body mass index (25-30 vs <25 kg/m²; 1.86 (1.19-2.89)) and back pain ((last 3 months) 1.55, 1.04-2.31), while for spinal BME, associations were found for age per decade (1.46, 1.13-1.90) and physically demanding work (1.46, 1.06-2.00). Record linkage was available for 694 (87.5%) participants and 9/694 (1.3%) had a record of axSpA (ICD M45.09).
CONCLUSION: These population-based data support the hypothesis of mechanic strain contributing to BME in the general population aged <45 years and the role of HLA-B27+ as a severity rather than a susceptibility factor for SIJ-BME. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  ankylosing; inflammation; magnetic resonance imaging; spondylitis

Mesh:

Substances:

Year:  2020        PMID: 33239274     DOI: 10.1136/annrheumdis-2020-218669

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  6 in total

Review 1.  Use of Imaging in Axial Spondyloarthritis for Diagnosis and Assessment of Disease Remission in the Year 2022.

Authors:  Ann-Sophie De Craemer; Zuzanna Łukasik; Philippe Carron
Journal:  Curr Rheumatol Rep       Date:  2022-10-15       Impact factor: 4.686

2.  [History of the treatment of axial spondylarthritis with biologics-Part 1].

Authors:  J Braun; J Sieper
Journal:  Z Rheumatol       Date:  2022-09-05       Impact factor: 1.530

3.  Evaluating the Impact of High Intensity Interval Training on Axial Psoriatic Arthritis Based on MR Images.

Authors:  Ioanna Chronaiou; Guro Fanneløb Giskeødegård; Ales Neubert; Tamara Viola Hoffmann-Skjøstad; Ruth Stoklund Thomsen; Mari Hoff; Tone Frost Bathen; Beathe Sitter
Journal:  Diagnostics (Basel)       Date:  2022-06-08

Review 4.  A glance into the future of diagnosis and treatment of spondyloarthritis.

Authors:  Victoria Navarro-Compán; Joerg Ermann; Denis Poddubnyy
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-07-22       Impact factor: 3.625

Review 5.  Pearls and Pitfalls in Diagnosing Non-Radiographic Axial Spondyloarthritis.

Authors:  Styliani Tsiami; Xenofon Baraliakos
Journal:  Mediterr J Rheumatol       Date:  2022-04-15

6.  [Answering epidemiologic rheumatologic questions by cooperation with the large population-based SHIP cohort-findings with relevance for the diagnosis of axial spondyloarthritis (axSpA)].

Authors:  J Braun; A Richter; C Schmidt; X Baraliakos
Journal:  Z Rheumatol       Date:  2021-07-15       Impact factor: 1.372

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.